Literature DB >> 4372745

Response of patients receiving high dose beclomethasone dipropionate.

J F Costello, T J Clark.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4372745      PMCID： PMC470201          DOI： 10.1136/thx.29.5.571

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  8 in total

1.  A RAPID TEST OF ADRENOCORTICAL FUNCTION.

Authors:  J B WOOD; A W FRANKLAND; V H JAMES; J LANDON
Journal:  Lancet       Date:  1965-01-30       Impact factor: 79.321

2.  A simple fluorimetric method for the estimation of free 11-hydroxycorticoids in human plasma.

Authors:  D MATTINGLY
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

3.  Aerosol beclomethasone dipropionate: a dose-response study in chronic bronchial asthma.

Authors:  J Gaddie; G R Petrie; I W Reid; C Skinner; D J Sinclair; K N Palmer
Journal:  Lancet       Date:  1973-08-11       Impact factor: 79.321

4.  Effect of beclomethasone dipropionate delivered by aerosol in patients with asthma.

Authors:  T J Clark
Journal:  Lancet       Date:  1972-06-24       Impact factor: 79.321

5.  Beclomethasone dipropionate by inhalation in the treatment of airways obstruction.

Authors:  Y F Choo-Kang; E J Cooper; A E Tribe; I W Grant
Journal:  Br J Dis Chest       Date:  1972-04

6.  Recovery of adrenal function after substitution of beclomethasone dipropionate for oral corticosteroids.

Authors:  D J Maberly; G J Gibson; A G Butler
Journal:  Br Med J       Date:  1973-03-31

7.  Comparison of beclomethasone dipropionate aerosol and prednisolone in reversible airways obstruction.

Authors:  S Lal; D M Harris; K K Bhalla; S N Singhal; A G Butler
Journal:  Br Med J       Date:  1972-08-05

8.  Beclomethasone dipropionate: a new steroid aerosol for the treatment of allergic asthma.

Authors:  H M Brown; G Storey; W H George
Journal:  Br Med J       Date:  1972-03-04
  8 in total
  14 in total

1.  Inhaled corticosteroids: benefits and risks.

Authors:  D M Geddes
Journal:  Thorax       Date:  1992-06       Impact factor: 9.139

2.  The place of beclomethasone dipropionate aerosol in the treatment of asthma.

Authors:  I Gregg
Journal:  Drugs       Date:  1975       Impact factor: 9.546

Review 3.  The place of high-dose inhaled corticosteroids in asthma therapy.

Authors:  M J Smith
Journal:  Drugs       Date:  1987-05       Impact factor: 9.546

Review 4.  Asthma: 2. Trends in pharmacologic therapy.

Authors:  A S Rebuck; K R Chapman
Journal:  CMAJ       Date:  1987-03-01       Impact factor: 8.262

5.  Effects of high doses of inhaled corticosteroids on adrenal function in children with severe persistent asthma.

Authors:  T K Ninan; I W Reid; P E Carter; P J Smail; G Russell
Journal:  Thorax       Date:  1993-06       Impact factor: 9.139

6.  Beclomethasone dipropionate inhaler: a review of its pharmacology, therapeutic value and adverse effects. I: Asthma.

Authors:  R N Brogden; R M Pinder; P R Sawyer; T M Speight; G S Avery
Journal:  Drugs       Date:  1975       Impact factor: 9.546

7.  A self management plan in the treatment of adult asthma.

Authors:  R Beasley; M Cushley; S T Holgate
Journal:  Thorax       Date:  1989-03       Impact factor: 9.139

Review 8.  Beclomethasone dipropionate. A reappraisal of its pharmacodynamic properties and therapeutic efficacy after a decade of use in asthma and rhinitis.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

9.  Comparison of two high dose corticosteroid aerosol treatments, beclomethasone dipropionate (1500 micrograms/day) and budesonide (1600 micrograms/day), for chronic asthma.

Authors:  P Ebden; A Jenkins; G Houston; B H Davies
Journal:  Thorax       Date:  1986-11       Impact factor: 9.139

10.  Experience of the use of beclomethasone dipropionate aerosol in general practice.

Authors:  I Gregg
Journal:  Br J Clin Pharmacol       Date:  1977       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.